Glen Eagle Advisors, LLC Edwards Lifesciences Corp Transaction History

Glen Eagle Advisors, LLC

$603 Billion
Q4 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 8,691 shares of EW stock, worth $625,404. This represents 0.11% of its overall portfolio holdings.

Number of Shares

8,691

Previous 13,369 34.99%

Holding current value

$625,404

Previous $882 Million 27.07%

% of portfolio

0.11%

Previous 0.15%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$64.54 - $75.92 $301,918 - $355,153	-4,678 Reduced 34.99%	8,691 $643 Million
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $63,043 - $99,031	-1,056 Reduced 7.32%	13,369 $882 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $1.19 Million - $1.34 Million	14,165 Added 5448.08%	14,425 $1.33 Billion
Q1 2024 Jul 03, 2024	BUY	$72.54 - $95.56 $686,228 - $903,997	9,460 New	9,460 $904 Million
Q4 2023 Aug 13, 2024	BUY	$61.71 - $77.76 $86,270 - $108,708	1,398 Added 209.6%	2,065 $157 Million
Q3 2021 Aug 13, 2024	SELL	$102.91 - $122.75 $2,366 - $2,823	-23 Reduced 3.33%	667 $75.5 Million
Q4 2020 Aug 13, 2024	SELL	$71.69 - $91.23 $628,721 - $800,087	-8,770 Reduced 92.71%	690 $62.9 Million
Q3 2020 Aug 13, 2024	SELL	$67.19 - $87.44 $201 - $262	-3 Reduced 0.39%	765 $61.1 Million
Q2 2020 Aug 13, 2024	BUY	$57.54 - $76.95 $30,956 - $41,399	538 Added 233.91%	768 $53.1 Million
Q1 2020 Aug 13, 2024	SELL	$52.41 - $81.0 $1,729 - $2,673	-33 Reduced 12.55%	230 $43.4 Million
Q4 2019 Aug 13, 2024	BUY	$71.7 - $82.09 $71 - $82	1 Added 0.38%	263 $61.4 Million
Q3 2019 Aug 13, 2024	BUY	$61.55 - $75.43 $1,969 - $2,413	32 Added 13.91%	262 $57.6 Million
Q1 2019 Aug 13, 2024	SELL	$47.89 - $64.05 $442,024 - $591,181	-9,230 Reduced 97.57%	230 $44 Million
Q4 2018 Aug 13, 2024	SELL	$46.41 - $56.94 $1,160 - $1,423	-25 Reduced 9.8%	230 $35.2 Million
Q3 2018 Aug 13, 2024	SELL	$45.7 - $58.03 $182 - $232	-4 Reduced 1.54%	255 $44.4 Million
Q2 2018 Aug 13, 2024	SELL	$42.45 - $51.3 $1.35 Million - $1.63 Million	-31,861 Reduced 99.19%	259 $37.7 Million
Q1 2018 Aug 14, 2024	SELL	$37.19 - $47.45 $342,148 - $436,540	-9,200 Reduced 97.25%	260 $36.3 Million
Q1 2018 Aug 13, 2024	BUY	$37.19 - $47.45 $1.19 Million - $1.52 Million	32,101 Added 168952.62%	32,120 $36.3 Million
Q4 2017 Aug 13, 2024	SELL	$33.79 - $39.39 $14,800 - $17,252	-438 Reduced 95.84%	19 $2.14 Million
Q3 2017 Aug 13, 2024	SELL	$36.29 - $38.83 $326,718 - $349,586	-9,003 Reduced 95.17%	457 $50 Million
Q2 2017 Aug 12, 2024	BUY	N/A	25 Added 14.29%	200 $23.6 Million
Q1 2017 Aug 12, 2024	BUY	N/A	50 Added 40.0%	175 $16.5 Million
Q4 2016 Aug 12, 2024	SELL	N/A	-9,335	125 $11.7 Million

Others Institutions Holding EW

# of Institutions

1,380

Shares Held

485M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Edwards Lifesciences Corp Transaction History